Conclusions: Our findings suggest that neonatal curcumin treatment elicits a therapeutic response through the restoration of hippocampal neurogenesis in BTBR mice and thus may represent a promising novel pharmacological strategy for ASD treatment. https://t.co/Zrb2ZzxVaE
— DCGreenZone1 (@DCGreenZone) June 23, 2022
Thursday, June 23, 2022
Neonatal curcumin treatment restores hippocampal neurogenesis and improves autism-related behaviors in a mouse model of autism
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment